Although numerous studies have successfully targeted these cancers, MYC remains a highly significant therapeutic target (Delmore et al, 2011; Kessler et al, 2012; Cermelli et al, 2014; Camarda et al, 2016; Horiuchi et al, 2016). Here, MYC is linked to cancer.